Due to a lack of suitable technology that can be used in an in-clinic setting, measurement of joint and soft tissue movement has been subjective and inconsistent. Mateligent’s stretch sensors are a vital component of new-to-the-world technology that is changing the paradigms of musculoskeletal health care. Mateligent sensors are temporarily worn on the body to measure muscle activation and timing of the soft tissue surrounding a joint, thereby providing a more complete picture of the musculoskeletal health.
After considering alternative technologies and partners, Figur8 partnered with Mateligent’s engineering team during a multiple-year project. Key criteria for this project included:
- Optimized electronics that would provide the speed and resolution needed to generate medical-grade data.
- Quality specifications that meet FDA device registration requirements and patient-facing appearance standards.
- Manufacturing process upgrades to meet enhanced quality specifications.
Numerous manufacturing experiments with new sensor formulations were conducted, and the results were jointly analyzed by Mateligent and Figur8. Over time, modified manufacturing processes were identified and implemented to achieve higher quality tolerances.
“We have appreciated the unwavering commitment of Mateligent as a strategic partner in the development of the Figur8s sEMG technology. Without their sensor technology, engineering expertise, and willingness to accommodate our requirements, we would be a very different-looking company today,” commented Nan-Wei Gong, Co-Founder & CEO of Figur8.”
